» Articles » PMID: 27142206

Trigger Factor Assisted Soluble Expression of Recombinant Spike Protein of Porcine Epidemic Diarrhea Virus in Escherichia Coli

Overview
Journal BMC Biotechnol
Publisher Biomed Central
Specialty Biotechnology
Date 2016 May 5
PMID 27142206
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Porcine epidemic diarrhea virus (PEDV) is a highly contagious enteric pathogen of swine. The spike glycoprotein (S) of PEDV is the major immunogenic determinant that plays a pivotal role in the induction of neutralizing antibodies against PEDV, which therefore is an ideal target for the development of subunit vaccine. In an attempt to develop a subunit vaccine for PEDV, we cloned two different fragments of S protein and expressed as glutathione S-transferase (GST)-tagged fusion proteins, namely rGST-COE and rGST-S1D, in E.coli. However, the expression of these recombinant protein antigens using a variety of expression vectors, strains, and induction conditions invariably resulted in inclusion bodies. To achieve the soluble expression of recombinant proteins, several chaperone co-expression systems were tested in this study.

Results: We firstly tested various chaperone co-expression systems and found that co-expression of trigger factor (TF) with recombinant proteins at 15 °C was most useful in soluble production of rGST-COE and rGST-S1D compared to GroEL-ES and DnaK-DnaJ-GrpE/GroEL-ES systems. The soluble rGST-COE and rGST-S1D were purified using glutathione Sepharose 4B with a yield of 7.5 mg/l and 5 mg/l, respectively. Purified proteins were detected by western blot using mouse anti-GST mAb and pig anti-PEDV immune sera. In an indirect ELISA, purified proteins showed immune reactivity with pig anti-PEDV immune sera. Finally, immunization of mice with 10 μg of purified proteins elicited highly potent serum IgG and serum neutralizing antibody titers.

Conclusions: In this study, soluble production of recombinant spike protein of PEDV, rGST-COE and rGST-S1D, were achieved by using TF chaperone co-expression system. Our results suggest that soluble rGST-COE and rGST-S1D produced by co-expressing chaperones may have the potential to be used as subunit vaccine antigens.

Citing Articles

Advances in porcine epidemic diarrhea virus research: genome, epidemiology, vaccines, and detection methods.

Zhuang L, Zhao Y, Shen J, Sun L, Hao P, Yang J Discov Nano. 2025; 20(1):48.

PMID: 40029472 PMC: 11876513. DOI: 10.1186/s11671-025-04220-y.


Development of an enzyme-linked immunosorbent assay based on viral antigen capture by anti-spike glycoprotein monoclonal antibody for detecting immunoglobulin A antibodies against porcine epidemic diarrhea virus in milk.

Li R, Wen Y, Yang L, Qian Q, Chen X, Zhang J BMC Vet Res. 2023; 19(1):46.

PMID: 36765329 PMC: 9921583. DOI: 10.1186/s12917-023-03605-4.


A Review: Molecular Chaperone-mediated Folding, Unfolding and Disaggregation of Expressed Recombinant Proteins.

Fatima K, Naqvi F, Younas H Cell Biochem Biophys. 2021; 79(2):153-174.

PMID: 33634426 DOI: 10.1007/s12013-021-00970-5.


Efficacy of orally administered porcine epidemic diarrhea vaccine-loaded hydroxypropyl methylcellulose phthalate microspheres and RANKL-secreting L. lactis.

Choe S, Song S, Piao D, Park G, Shin J, Choi Y Vet Microbiol. 2020; 242:108604.

PMID: 32122610 PMC: 7117268. DOI: 10.1016/j.vetmic.2020.108604.


Enhancement of antigen-specific humoral immune responses and protein solubility through conjugation of bacterial flagellin, FlaB, to the N-terminus of porcine epidemic diarrhea virus surface protein antigen S0.

Oh S, Kim Cho Y, Lee H, Lee S, Kim W, Hong L J Vet Sci. 2019; 20(6):e70.

PMID: 31775197 PMC: 6883195. DOI: 10.4142/jvs.2019.20.e70.


References
1.
Ojkic D, Hazlett M, Fairles J, Marom A, Slavic D, Maxie G . The first case of porcine epidemic diarrhea in Canada. Can Vet J. 2015; 56(2):149-52. PMC: 4298265. View

2.
Li W, Li H, Liu Y, Pan Y, Deng F, Song Y . New variants of porcine epidemic diarrhea virus, China, 2011. Emerg Infect Dis. 2012; 18(8):1350-3. PMC: 3414035. DOI: 10.3201/eid1808.120002. View

3.
Follis K, York J, Nunberg J . Furin cleavage of the SARS coronavirus spike glycoprotein enhances cell-cell fusion but does not affect virion entry. Virology. 2006; 350(2):358-69. PMC: 7111780. DOI: 10.1016/j.virol.2006.02.003. View

4.
Singh A, Upadhyay V, Upadhyay A, Singh S, Panda A . Protein recovery from inclusion bodies of Escherichia coli using mild solubilization process. Microb Cell Fact. 2015; 14:41. PMC: 4379949. DOI: 10.1186/s12934-015-0222-8. View

5.
Yamaguchi H, Miyazaki M . Refolding techniques for recovering biologically active recombinant proteins from inclusion bodies. Biomolecules. 2014; 4(1):235-51. PMC: 4030991. DOI: 10.3390/biom4010235. View